Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.06.2017 | Case report

Cisplatin/gemcitabine

Neutropenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Cho MH, et al. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review. World Journal of Surgical Oncology 14: 270, No. 1, 20 Oct 2016. Available from: URL: http://doi.org/10.1186/s12957-016-1021-3 - SouthKorea Cho MH, et al. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review. World Journal of Surgical Oncology 14: 270, No. 1, 20 Oct 2016. Available from: URL: http://​doi.​org/​10.​1186/​s12957-016-1021-3 - SouthKorea
Metadaten
Titel
Cisplatin/gemcitabine
Neutropenia: case report
Publikationsdatum
01.06.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-31479-7

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Ibrutinib

Case report

Imatinib

Case report

Tenofovir